MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jamaneurol.2016.5537

Медицинская библиотека · JAMA neurology · 2017

Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA.

Berger Joseph R, Miller Craig S, Danaher Robert J, Doyle Kathryn, Simon Kenneth J, Norton Elizabeth, Gorelik Leonid, Cahir-McFarland Ellen, Singhal Divya, Hack Nawaz, Owens Joseph Ryan, Nelson Peter T, Neltner Janna H

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

IMPORTANCE

Although seroepidemiological studies indicate that greater than 50% of the population has been infected with John Cunningham virus (JCV), the sites of JCV persistence remain incompletely characterized.

OBJECTIVE

To determine sites of JCV persistence in immunologically healthy individuals.

DESIGN, SETTING, AND

PARTICIPANTS

Tissue specimens from multiple sites including brain, renal, and nonrenal tissues were obtained at autopsy performed in the Department of Pathology at the University of Kentucky from 12 immunologically healthy patients between February 9, 2011, and November 27, 2012. Quantitative polymerase chain reaction was performed on the tissue specimens and urine. Serum JCV antibody status was determined by enzyme-linked immunosorbent assay.

MAIN OUTCOMES AND MEASURES: The detection and quantification of JCV from the tissues by quantitative polymerase chain reaction illuminated sites of viral persistence. These results were correlated with JCV antibody levels.

RESULTS

Autopsies were performed on 12 individuals, 10 men and 2 women, ranging in age from 25 to 75 years (mean, 55.3 years). Seven of 12 individuals were JCV antibody seropositive based on absorbance units. Serostatus was associated with amounts of JCV DNA in urine and its tissue distribution. John Cunningham virus DNA was found in 75% of genitourinary tissue samples from donors (18 of 24) with high JCV antibody levels, 13.3% of donors with low levels i(4 of 30), and 0% of seronegative persons (0 of 32). In nongenitourinary tissues, JCV DNA was detected in 45.1% of tissue samples of donors (32 of 71) with high JCV, 2.2% of donors with low JCV serostatus (2 of 93), and 0% of seronegative persons (0 of 43). Genitourinary tissues had higher copy numbers than other sites. John Cunningham virus DNA was detected in urine of seronegative individuals in a research-grade assay.

CONCLUSIONS AND RELEVANCE: Persistent (latent or actively replicating) JCV infection mostly predominates in genitourinary tissues but distributes in other tissues at low copy number. The distribution and copy numbers of the virus appear to correlate with urinary JCV shedding and serostatus.

Для цитирования: Berger Joseph R, Miller Craig S, Danaher Robert J, Doyle Kathryn, Simon Kenneth J, Norton Elizabeth, Gorelik Leonid, Cahir-McFarland Ellen, Singhal Divya, Hack Nawaz, Owens Joseph Ryan, Nelson Peter T, Neltner Janna H. Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA.. JAMA neurology. 2017. DOI: 10.1001/jamaneurol.2016.5537.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.